Background: Hepatocellular carcinoma (HCC) originates from the hepatocytes and accounts
for 90% of liver cancer. The study intends to identify novel prognostic biomarkers for …

Hepatocellular carcinoma is a common malignant tumor with poor prognosis, poor treatment
effect, and lack of effective biomarkers. In this study, bioinformatics analysis of immune …

Immune-related genes play a key role in regulating the cancer immune microenvironment,
influencing the overall survival of patients with hepatocellular carcinoma (HCC). Along with …

Background: Due to the heterogeneity of hepatocellular carcinoma (HCC), hepatocelluarin-
associated differentially expressed genes were analyzed by bioinformatics methods to …

Background Hepatocellular carcinoma (HCC) ranks the fourth in terms of cancer-related
mortality globally. Herein, in this research, we attempted to develop a novel immune-related …

Background: The prognosis of patients with hepatocellular carcinoma (HCC) is negatively
affected by the lack of effective prognostic indicators. The change of tumor immune …

Background Growing evidence has suggested that immune-related genes play crucial roles
in the development and progression of hepatocellular carcinoma (HCC). Nevertheless, the …

Liver hepatocellular carcinoma (LIHC), an inflammation-associated cancer induced by a
variety of etiological factors, is still one of the most prevalent and lethal cancers in human …

Background Hepatocellular carcinoma (HCC) is a serious malignant disease with high
incidence, high mortality and poor prognosis. This study aimed to establish a novel …

Background Given poor prognosis and the lack of efficient therapy for advanced
hepatocellular carcinoma, immunotherapy has emerged as an increasingly important role …